Company: BLNE
Filing Date: 2025-03-26
Form Type: 424B7
Source: 0001641172-25-000695
Chunk: 13

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-26
Form: 424B7
Chunk 13
---
 dilution to existing shareholders) which may result therefrom.

We may not be able to access sufficient funds under the Purchase Agreement with C/M when needed.

Our ability to sell shares to C/M and obtain funds under the Purchase Agreement is limited by the terms and conditions in the Purchase Agreement, including restrictions on when we may sell shares to C/M, restrictions on the amounts we may sell to C/M at any one time, and a limitation on our ability to sell shares to C/M to the extent that it would cause C/M to beneficially own more than 4.99% of our outstanding common stock. In addition, any amounts we sell under the Purchase Agreement may not satisfy all of our funding needs, even if we are able and choose to sell all $10,000,000 under the Purchase Agreement. The sale of the full $10,000,000 could also be further delayed by our need to file a subsequent registration statement on Form S-1 and have such registration statement to be declared effective by the SEC in order to make further sales beyond the up to $2,500,000 being offered hereby and the up to $1,500,000 under the prior prospectus supplement filed on March 10, 2025 relating to shares issuable under the Purchase Agreement. If we elect to issue and sell more than the shares offered under this prospectus supplement to C/M, which we have the right, but not the obligation, to do, we must first register for resale under the Securities Act any such additional shares.

| S-16 |

We elected to enter into the Purchase Agreement with C/M as a means to access capital quickly as market conditions permit. The extent we rely on C/M as a source of funding will depend on a number of factors including, the prevailing market price and trading volume of our common stock and the extent to which we are able to secure working capital from other sources including an at-the-market offering. We recently executed an engagement letter with a broker-dealer which will be or exclusive sales agent under an at-the-market offering. Subject to their due diligence and customary conditions, we expect a definitive At-the Market Offering Agreement in April 2025. We cannot assure you we will receive any proceeds from the at-the-market offering. Further, the two concurrent offerings may result in us using the at-the-market offering since it will entail a 3% commission. If obtaining sufficient funding from C/M were to prove unavailable or prohibitively dilutive, we will need to secure another source of funding in order to